TherioPharm SRL
TherioPharm reported total assets of 9,763 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of TherioPharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +49 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TherioPharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
TherioPharm's financial analysis
- Solvency-1.2%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TherioPharm
TherioPharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0715.780.024
- VAT number
- BE0715780024
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 13 Dec 2018
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
TherioPharm (SRL) has been based in Wavre since 2018, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 4,423 € and equity of −113 €; its revenue is not published. Its solvency stands at -1.2%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to TherioPharm
Companies in the same business, of comparable size and area, outside its group.
- DSP2 Pre-press and pre-media services Lummen · balance sheet 9,749 €
- Nomad Golf Operation of sports facilities Uccle · balance sheet 9,778 €
- Legal Invest Activities of holding companies Ixelles · balance sheet 9,650 €
- Service Bureau Braems Rental and operating of own or leased real estate Brussels · balance sheet 9,892 €
- CHTF-II Invest Activities of holding companies Leuven · balance sheet 9,630 €
- LaFinya Participaties Other information service activities Lanaken · balance sheet 9,626 €
- CBJ Saint-Gilles · balance sheet 9,916 €
Frequently asked questions about TherioPharm
What is the revenue of TherioPharm?
TherioPharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TherioPharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0715780024 for TherioPharm, if the company is VAT-registered. Its company number (CBE) is 0715.780.024.
Where is the registered office of TherioPharm?
According to the CBE register, the registered office of TherioPharm is in 1300 Wavre.
What is the equity of TherioPharm?
At the close of the 2025 financial year, the equity of TherioPharm amounts to -113 €, a solvency of -1.2% of total assets.
Who manages TherioPharm?
The register lists 1 active mandates at TherioPharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TherioPharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →